Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

3.

A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.

Adriaenssens E, Mougel A, Goormachtigh G, Loing E, Fafeur V, Auriault C, Coll J.

Oncogene. 2004 Apr 8;23(15):2681-93. Erratum in: Oncogene. 2004 Oct 21;23(49):8184.

PMID:
14767477
5.

Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.

Chuang HC, Lay JD, Hsieh WC, Wang HC, Chang Y, Chuang SE, Su IJ.

Blood. 2005 Nov 1;106(9):3090-6. Epub 2005 Jul 7.

6.

EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.

Grimm T, Schneider S, Naschberger E, Huber J, Guenzi E, Kieser A, Reitmeir P, Schulz TF, Morris CA, St├╝rzl M.

Blood. 2005 Apr 15;105(8):3263-9. Epub 2004 Dec 21.

7.
8.

Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.

Chuang HC, Wang JM, Hsieh WC, Chang Y, Su IJ.

Am J Pathol. 2008 Nov;173(5):1397-405. doi: 10.2353/ajpath.2008.080440. Epub 2008 Oct 2.

9.

Decoy receptor 3, upregulated by Epstein-Barr virus latent membrane protein 1, enhances nasopharyngeal carcinoma cell migration and invasion.

Ho CH, Chen CL, Li WY, Chen CJ.

Carcinogenesis. 2009 Aug;30(8):1443-51. doi: 10.1093/carcin/bgp135. Epub 2009 May 29.

PMID:
19483191
10.

Inhibition of tumor necrosis factor-induced phenotypes by short intracellular versions of latent membrane protein-1.

Ndour PA, Ouk TS, Brocqueville G, Mougel A, Vanhecke E, Feuillard J, Coll J, Adriaenssens E.

Cell Signal. 2010 Feb;22(2):303-13. doi: 10.1016/j.cellsig.2009.09.037. Epub 2009 Sep 29.

PMID:
19796681
11.

Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.

Park CH, Kim HR, Kim J, Jang SH, Lee KY, Chung GH, Jang YS.

J Cell Biochem. 2004 Mar 1;91(4):777-85.

PMID:
14991769
12.

Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.

Okudaira T, Yamamoto K, Kawakami H, Uchihara JN, Tomita M, Masuda M, Matsuda T, Sairenji T, Iha H, Jeang KT, Matsuyama T, Takasu N, Mori N.

Br J Haematol. 2006 Feb;132(3):293-302. Retraction in: Br J Haematol. 2011 Mar;152(6):787.

PMID:
16409294
13.

Pursuing different 'TRADDes': TRADD signaling induced by TNF-receptor 1 and the Epstein-Barr virus oncoprotein LMP1.

Kieser A.

Biol Chem. 2008 Oct;389(10):1261-71. doi: 10.1515/BC.2008.144. Review.

PMID:
18713013
14.

Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.

J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57.

PMID:
15467034
15.
19.

HBx-induced hepatic steatosis and apoptosis are regulated by TNFR1- and NF-kappaB-dependent pathways.

Kim JY, Song EH, Lee HJ, Oh YK, Choi KH, Yu DY, Park SI, Seong JK, Kim WH.

J Mol Biol. 2010 Apr 9;397(4):917-31. doi: 10.1016/j.jmb.2010.02.016. Epub 2010 Feb 13.

PMID:
20156456

Supplemental Content

Support Center